Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Kimryn Rathmell

GU Oncology · Arthur G James Cancer Hospital

View

Dr. Patrick Pilie

GU Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    DKDr. Daniel Kwon

    Dr. Daniel Kwon

    Medical Oncology · Genitourinary Oncology
    University of California, San Francisco
    danielkwon

    Research

    Veterans' Decision Making for Prostate Cancer Germline Testing After Informed Consent With Their Oncologist: A Mixed-Methods Study

    2025

    Via JCO Oncology Practice

    Research

    Shared Decision-Making Needs, Barriers, and Facilitators of Patients With Newly Diagnosed Advanced Cancer in the Hospital: A Multi-Level, Mixed-Methods Study

    2024

    Via Supportive Care in Cancer

    Research

    Accuracy, Readability, and Quality of Websites About Metastatic Renal Cell Carcinoma Treatment

    2024

    Via Urologic Oncology

    Research

    Germline Testing for Veterans With Advanced Prostate Cancer: Concerns About Service-Connected Benefits

    2024

    Via JNCI Cancer Spectrum

    Research

    Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer

    2024

    Via Cancer Medicine

    Research

    Clinical Characteristics, Racial Inequities, and Outcomes in Patients With Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

    2023

    Via medRxiv

    Research

    Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer

    2023

    Via JCO Oncology Practice

    Research

    Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects

    2023

    Via European Urology Focus

    Research

    Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

    2023

    Via JAMA Oncology

    Research

    Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19

    2023

    Via JAMA Oncology

    Research

    COVID-19 Severity and Cardiovascular Outcomes in SARS-CoV-2-Infected Patients With Cancer and Cardiovascular Disease

    2023

    Via Translational Oncology

    Research

    Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin

    2023

    Via Clinical Genitourinary Cancer

    Research

    Somatic Alterations Associated With Response to Enfortumab Vedotin in Patients With Advanced Urothelial Cancer

    2023

    Via Frontiers in Oncology

    Research

    Single-Dose Lu-PSMA-617 Followed by Maintenance Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer: An Open-Label, Dose-Expansion, Phase 1 Trial

    2023

    Via The Lancet Oncology

    Research

    Demographics, Outcomes, and Risk Factors for Patients With Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

    2022

    Via Cancers